Showing results (61-70 of 78) with videos related to

Sort By:
Pageof 8
Acta Psychiatrica Scandinavica|June 27, 2015
Relationship between prolactin, breast cancer risk, and antipsychotics in patients with schizophrenia: a critical reviewM De Hert, J Peuskens, T Sabbe, et al.
Social Psychiatry and Psychiatric Epidemiology|January 5, 2002
Expressed emotion in staff-patient relationships: the professionals' and residents' perspectivesG Van Humbeeck, C Van Audenhove, G Pieters, et al.
Social Psychiatry and Psychiatric Epidemiology|August 27, 2002
Expressed emotion in the client-professional caregiver dyad: are symptoms, coping strategies and personality related?G Van Humbeeck, Ch Van Audenhove, G Pieters, et al.
The British Journal of Psychiatry : the Journal of Mental Science|August 2, 2011
Guidelines for screening and monitoring of cardiometabolic risk in schizophrenia: systematic evaluationM De Hert, D Vancampfort, C U Correll, et al.
Current Medical Research and Opinion|December 18, 2009
Treatment retention with risperidone long-acting injection: 24-month results from the Electronic Schizophrenia Treatment Adherence Registry (e-STAR) in six countriesJ Peuskens, J M Olivares, J Pecenak, et al.
Acta Psychiatrica Scandinavica. Supplementum|January 1, 1990
A double-blind comparative study of remoxipride and haloperidol in schizophrenic and schizophreniform disordersJ Mendlewicz, E de Bleeker, P Cosyns, et al.
Psychiatry Research|November 25, 1996
Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imagingA Rosier, P Dupont, J Peuskens, et al.
Journal of Psychiatric Research|October 3, 2006
Predictors of risk for relapse in patients with schizophrenia or schizoaffective disorder during olanzapine drug therapyI Lipkovich, W Deberdt, J G Csernansky, et al.
Acta Psychiatrica Scandinavica|April 1, 1992
Ventricular enlargement, clinical correlates and treatment outcome in chronic schizophrenic inpatientsG Wilms, C Van Ongeval, A L Baert, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|September 17, 2011
A prospective, multicentre, open-label study to evaluate the effectiveness of aripiprazole in the treatment of a broad range of patients with schizophreniaJ Peuskens, C Bervoets, F Kok, et al.
Pageof 8